Cellular repressor of E1A-stimulated genes inhibits human vascular smooth muscle cell apoptosis via blocking P38/JNK MAP kinase activation

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 6, 2010, Pages 1225-1235

  Han, Yaling ^a   Wu, Guangzhe ^b   Deng, Jie ^a   Tao, Jie ^a   Guo, Liang ^a   Tian, Xiaoxiang ^a   Kang, Jian ^a   Zhang, Xiaolin ^a   Yan, Chenghui ^a  

^a SHENYANG NORTHERN HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; E1A; Repressor protein; Signaling pathway; Vascular smooth muscle cells

Indexed keywords

CASPASE 3; CELLULAR REPRESSOR OF E1A STIMULATED GENE PROTEIN; GLYCOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RETROVIRUS INFECTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADENOVIRUS E1A PROTEINS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; MESENCHYMAL STEM CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REPRESSOR PROTEINS; RETROVIRIDAE; SIGNAL TRANSDUCTION; THORACIC ARTERIES; TIME FACTORS;

EID: 77952671940     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.12.018     Document Type: Article

References (31)

1. Mallat Z., Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ. Res. 2001, 88:998-1003.
2. Bennett M.R. Vascular smooth muscle cell apoptosis-a dangerous phenomenon in vascular disease?. J. Clin. Basic Cardiol. 2000, 3:63-65.
3. Bennett M.R., Macdonald K., Chan S.W., Boyle J.J., Weissberg P.L. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ. Res. 1998, 82:704-712.
4. McCarthy N.J., Bennett M.R. The regulation of vascular smooth muscle cell apoptosis. Cardiovasc. Res. 2000, 45:747-755.
5. Libby P., Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 2002, 8(11):1257-1262.
6. Spiguel LR, Chandiwal A, Vosicky JE, Weichselbaum RR, Skelly CL. Concomitant proliferation and caspase-3 mediated apoptosis in response to low shear stress and balloon injury. J Surg Res 2009 (in press).
7. Veal E., Eisenstein M., Tseng Z.H., Gill G. A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Mol. Cell Biol. 1998, 18(9):5032-5041.
8. Han Y.L., Liu H.W., Kang J., Yan C.H., Wang X.Z., Zhao L.Y., et al. [Expression of cellular repressor of E1A-stimulated genes in vascular smooth muscle cells of different phenotypes]. Zhonghua Yi Xue Za Zhi. 2005, 85(1):49-53.
9. Small T.W., Bolender Z., Bueno C., O'Neil C., Nong Z., Rushlow W., et al. Wilms' tumor 1-associating protein regulates the proliferation of vascular smooth muscle cells. Circ. Res. 2006, 99(12):1338-1346.
10. Han Y.L., Guo P., Sun M.Y., Guo L., Luan B., Kang J., et al. Secreted CREG inhibits cell proliferation mediated by mannose 6-phosphate/insulin-like growth factor II receptor in NIH3T3 fibroblasts. Genes Cells. 2008, 13(9):977-986.
11. Di Bacco A., Gill G. The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor. Oncogene 2003, 22(35):5436-5445.
12. Veal E., Groisman R., Eisenstein M., Gill G. The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells. Oncogene 2000, 19(17):2120-2128.
13. Han Y., Deng J., Guo L., Yan C., Liang M., Kang J., et al. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery. Cardiovasc. Res. 2008, 78(3):597-604.
14. Han Y., Guo L., Yan C., Guo P., Deng J., Mai X., et al. Adenovirus-mediated intra-arterial delivery of cellular repressor of E1A-stimulated genes inhibits neointima formation in rabbits after balloon injury. J. Vasc. Surg. 2008, 48(1):201-209.
15. Han Y.L., Xu H.M., Deng J., Hu Y., Kang J., Liu H.W., et al. Over-expression of the cellular repressor of E1A-stimulated genes inhibits the apoptosis of human vascular smooth muscle cells in vitro. Sheng Li Xue Bao 2006, 58(4):324-330.
16. Qi X., Pohl N.M., Loesch M., Hou S., Li R., Qin J.Z., et al. p38alpha antagonizes p38gamma activity through c-Jun-dependent ubiquitin-proteasome pathways in regulating Ras transformation and stress response. J. Biol. Chem. 2007, 282(43):31398-31408.
17. Ono K., Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 2000, 12(1):1-13.
18. Nebreda A.R., Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 2000, 25(6):257-260.
19. Kennedy N.J., Cellurale C., Davis R.J. A radical role for p38 MAPK in tumor initiation. Cancer Cell. 2007, 11(2):101-103.
20. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81(2):807-869.
21. Chen G., Hitomi M., Han J., Stacey D.W. The p38 pathway provides negative feedback for Ras proliferative signaling. J. Biol. Chem. 2000, 275(50):38973-38980.
22. Shen Y.H., Godlewski J., Zhu J., Sathyanarayana P., Leaner V., Birrer M.J., et al. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors. J. Biol. Chem. 2003, 278(29):26715-26721.
23. Shi G.X., Han J., Andres D.A. Rin GTPase couples nerve growth factor signaling to p38 and b-Raf/ERK pathways to promote neuronal differentiation. J. Biol. Chem. 2005, 280(45):37599-37609.
24. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270(5240):1326-1331.
25. Bian Z., Cai J., Shen D.F., Chen L., Yan L., Tang Q., et al. Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis. J. Cell Mol. Med. 2009, 13(7):1302-1313.
26. Xu L., Liu J.M., Chen L.Y. CREG, a new regulator of ERK1/2 in cardiac hypertrophy. J. Hypertens. 2004, 22(8):1579-1587.
27. Gordon P.V., Paxton J.B., Fox N.S. The cellular repressor of E1A-stimulated genes mediates glucocorticoid-induced loss of the type-2 IGF receptor in ileal epithelial cells. J. Endocrinol. 2005, 185(2):265-273.
28. Pollman M.J., Hall J.L., Gibbons G.H. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. Circ. Res. 1999, 84(1):113-121.
29. Perlman H., Maillard L., Krasinski K., Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 1997, 95(4):981-987.
30. Bennett M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc. Res. 1999, 41(2):361-368.
31. Cheng W.P., Hung H.F., Wang B.W., Shyu K.G. The molecular regulation of GADD153 in apoptosis of cultured vascular smooth muscle cells by cyclic mechanical stretch. Cardiovasc. Res. 2008, 77(3):551-559.